Hehui Fang
305 East Zhongshan Road
Nanjing, 210002, China
Nanjing, 210002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Salvage dacomitinib plus intraventricular pemetrexed for leptomeningeal metastasis after failure of third‑generation EGFR‑TKIs in EGFR‑mutant NSCLC: an ambispective cohort study.
Journal: Journal of neuro-oncology
Published: February 13, 2026
Serial monitoring of cerebrospinal fluid in patients with leptomeningeal metastases in lung cancer via the Ommaya reservoir as a predictive indicator of therapeutic efficacy and clinical prognosis.
Journal: NPJ precision oncology
Published: April 02, 2025
Furmonertinib in uncommon EGFR-mutated non-small cell lung cancer with central nervous system metastases: A retrospective cohort study.
Journal: International journal of cancer
Published: January 21, 2025
Genomic profiling and prognostic factors of leptomeningeal metastasis in EGFR-mutant NSCLC after resistant to third-generation EGFR-tyrosine kinase inhibitors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 16, 2024
Real-world study of first-line therapy with aumolertinib for elderly patients with non-small cell lung cancer harboring EGFR mutation.
Journal: Medicine
Published: June 01, 2024
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer.
Journal: Journal of neuro-oncology
Published: April 21, 2024
Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
Journal: Neoplasia (New York, N.Y.)
Published: February 06, 2018
PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells.
Journal: Cancer science
Published: December 16, 2017
Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer.
Journal: Breast cancer research and treatment
Published: September 07, 2017
An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer.
Journal: Cell death and differentiation
Published: August 24, 2017
Intratumor heterogeneity predicts metastasis of triple-negative breast cancer.
Journal: Carcinogenesis
Published: February 25, 2017
Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
Journal: International journal of biological sciences
Published: July 17, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026